Securities and Exchange Commission

Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent

Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.

Compare To Other Companies

Annual (pure)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
-0.069	2016-12-29	10-K	2016	FY	2014-10-01	2015-09-30	CY2015
0	2018-12-18	10-K	2018	FY	2016-10-01	2017-09-30	CY2017
-0.229	2019-12-19	10-K	2019	FY	2017-10-01	2018-09-30	CY2018
0.008	2020-12-23	10-K	2020	FY	2018-10-01	2019-09-30	CY2019
0.033	2021-12-23	10-K	2021	FY	2019-10-01	2020-09-30	CY2020
-0.037	2022-12-29	10-K	2022	FY	2020-10-01	2021-09-30	CY2021
-0.035	2023-12-22	10-K	2023	FY	2021-10-01	2022-09-30	CY2022
-0.013	2024-12-27	10-K	2024	FY	2022-10-01	2023-09-30	CY2023
-0.024	2024-12-27	10-K	2024	FY	2023-10-01	2024-09-30	CY2024

All Reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent (pure)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
-0.069	2016-12-29	10-K	2016	FY	2014-10-01	2015-09-30	CY2015
0	2018-12-18	10-K	2018	FY	2016-10-01	2017-09-30	CY2017
-0.229	2018-12-18	10-K	2018	FY	2017-10-01	2018-09-30
-0.229	2019-12-19	10-K	2019	FY	2017-10-01	2018-09-30	CY2018
0.008	2019-12-19	10-K	2019	FY	2018-10-01	2019-09-30
0.008	2020-12-23	10-K	2020	FY	2018-10-01	2019-09-30	CY2019
0.033	2020-12-23	10-K	2020	FY	2019-10-01	2020-09-30
0.033	2021-12-23	10-K	2021	FY	2019-10-01	2020-09-30	CY2020
-0.037	2021-12-23	10-K	2021	FY	2020-10-01	2021-09-30
-0.037	2022-12-29	10-K	2022	FY	2020-10-01	2021-09-30	CY2021
-0.035	2022-12-29	10-K	2022	FY	2021-10-01	2022-09-30
-0.035	2023-12-22	10-K	2023	FY	2021-10-01	2022-09-30	CY2022
-0.013	2023-12-22	10-K	2023	FY	2022-10-01	2023-09-30
-0.013	2024-12-27	10-K	2024	FY	2022-10-01	2023-09-30	CY2023
-0.024	2024-12-27	10-K	2024	FY	2023-10-01	2024-09-30	CY2024